
BridgeBio Pharma Inc (BBIO) gets rating Resumed from Raymond James
BridgeBio Pharma Inc’s recent filing unveils that its President and CFO Trimarchi Thomas unloaded Company’s shares for reported $2.09 million
BridgeBio Pharma Inc’s recent filing unveils that its President and CFO Trimarchi Thomas unloaded Company’s shares for reported $2.09 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
BridgeBio Pharma Inc’s filing revealed that its Director HOMCY CHARLES J unloaded Company’s shares for reported $11.51 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, BridgeBio Pharma Inc revealed its Director CHARLES J HOMCY acquired Company’s shares for reported $11.51 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BridgeBio Pharma
BridgeBio Pharma Inc’s filing revealed that its Chief Executive Officer Kumar Neil unloaded Company’s shares for reported $1.71 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or